Show simple item record

dc.contributor.authorMartín Fernández, Marta 
dc.contributor.authorArroyo, Víctor
dc.contributor.authorCarnicero, Carmen
dc.contributor.authorSigüenza, Rebeca
dc.contributor.authorBusta, Reyes
dc.contributor.authorMora, Natalia
dc.contributor.authorAntolín, Beatriz
dc.contributor.authorTamayo Gómez, Eduardo 
dc.contributor.authorAspichueta, Patricia
dc.contributor.authorCarnicero-Frutos, Irene
dc.contributor.authorGonzalo Benito, Hugo
dc.contributor.authorAller de la Fuente, Rocío 
dc.date.accessioned2024-01-15T14:14:12Z
dc.date.available2024-01-15T14:14:12Z
dc.date.issued2022
dc.identifier.citationAntioxidants (Basel). 2022 Nov 10;11(11):2217es
dc.identifier.urihttps://uvadoc.uva.es/handle/10324/64525
dc.description.abstractNon-alcoholic fatty liver disease (NAFLD) is characterised by an excess of hepatic fat that can progress to steatohepatitis, fibrosis, cirrhosis and hepatocarcinoma. The imbalance between lipid uptake/lipogenesis and lipid oxidation/secretion in the liver is a major feature of NAFLD. Given the lack of a non-invasive and reliable methods for the diagnosis of non-alcoholic steatohepatitis (NASH), it is important to find serum markers that are capable of discriminating or defining patients with this stage of NASH. Blood samples were obtained from 152 Caucasian subjects with biopsy-proven NAFLD due to persistently elevated liver enzyme levels. Metabolites representative of oxidative stress were assessed. The findings derived from this work revealed that NAFLD patients with a NASH score of ≥ 4 showed significantly higher levels of lipid peroxidation (LPO). Indeed, LPO levels above the optimal operating point (OOP) of 315.39 μM are an independent risk factor for presenting a NASH score of ≥ 4 (OR: 4.71; 95% CI: 1.68−13.19; p = 0.003). The area under the curve (AUC = 0.81, 95% CI = 0.73−0.89, p < 0.001) shows a good discrimination ability of the model. Therefore, understanding the molecular mechanisms underlying the basal inflammation present in these patients is postulated as a possible source of biomarkers and therapeutic targets in NASH.es
dc.format.mimetypeapplication/pdfes
dc.language.isospaes
dc.publisherMDPIes
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.titleRole of Oxidative Stress and Lipid Peroxidation in the Pathophysiology of NAFLDes
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.doi10.3390/antiox11112217es
dc.identifier.publicationfirstpage2217es
dc.identifier.publicationissue11es
dc.identifier.publicationtitleAntioxidantses
dc.identifier.publicationvolume11es
dc.peerreviewedSIes
dc.description.projectCONSEJERIA DE EDUCACION DE CASTILLA Y LEONes
dc.identifier.essn2076-3921es
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record